Published in Nat Genet on November 01, 1994
Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 4.33
Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet (2009) 3.38
c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev (2000) 3.13
Waardenburg syndrome. J Med Genet (1997) 2.66
Multiple hits during early embryonic development: digenic diseases and holoprosencephaly. Am J Hum Genet (2002) 2.49
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol (2003) 1.90
MicroRNA-204/211 alters epithelial physiology. FASEB J (2010) 1.83
Shadows of complexity: what biological networks reveal about epistasis and pleiotropy. Bioessays (2009) 1.82
Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol (1999) 1.80
Sox5 functions as a fate switch in medaka pigment cell development. PLoS Genet (2014) 1.80
Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci U S A (2003) 1.73
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clin Cancer Res (2006) 1.72
NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family. Mol Cell Biol (1996) 1.67
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog. Proc Natl Acad Sci U S A (2006) 1.61
Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol Cell Biol (1998) 1.59
Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4. Am J Hum Genet (2007) 1.54
Interplay between Foxd3 and Mitf regulates cell fate plasticity in the zebrafish neural crest. Dev Biol (2010) 1.44
Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus. Genetics (2000) 1.37
Light and inherited retinal degeneration. Br J Ophthalmol (2006) 1.37
Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling. EMBO J (2002) 1.37
Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J Clin Invest (2000) 1.37
Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med (1998) 1.35
Brachyury-related transcription factor Tbx2 and repression of the melanocyte-specific TRP-1 promoter. Mol Cell Biol (1998) 1.28
Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner. Pigment Cell Res (2005) 1.28
MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. J Invest Dermatol (2008) 1.23
A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy. Hum Mol Genet (2008) 1.16
At the speed of sound: gene discovery in the auditory system. Am J Hum Genet (2001) 1.15
The murine misty mutation: phenotypic effects on melanocytes, platelets and brown fat. Genetics (1998) 1.14
Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21. Am J Hum Genet (1997) 1.11
MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Biochem J (2006) 1.11
Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF. Proc Natl Acad Sci U S A (2011) 1.09
Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Am J Hum Genet (1996) 1.09
Transcription factor MITF regulates cardiac growth and hypertrophy. J Clin Invest (2006) 1.07
Comparison of melanoblast expression patterns identifies distinct classes of genes. Pigment Cell Melanoma Res (2009) 1.07
Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2. J Exp Med (2000) 1.05
The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys (2014) 1.05
The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J (1996) 1.04
The new dysmorphology: application of insights from basic developmental biology to the understanding of human birth defects. Proc Natl Acad Sci U S A (1995) 1.03
MITF-siRNA formulation is a safe and effective therapy for human melasma. Mol Ther (2010) 1.01
Interspecies difference in the regulation of melanocyte development by SOX10 and MITF. Proc Natl Acad Sci U S A (2006) 0.99
Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol (2014) 0.97
MITF in melanoma: mechanisms behind its expression and activity. Cell Mol Life Sci (2014) 0.97
Myotonic dystrophy: molecular windows on a complex etiology. Nucleic Acids Res (1998) 0.95
Genetic variations strongly influence phenotypic outcome in the mouse retina. PLoS One (2011) 0.95
The discovery of the microphthalmia locus and its gene, Mitf. Pigment Cell Melanoma Res (2010) 0.94
Role played by microphthalmia transcription factor phosphorylation and its Zip domain in its transcriptional inhibition by PIAS3. Mol Cell Biol (2003) 0.94
Exclusion of linkage to the CDL1 gene region on chromosome 3q26.3 in some familial cases of Cornelia de Lange syndrome. Am J Med Genet (2001) 0.94
BEST1 expression in the retinal pigment epithelium is modulated by OTX family members. Hum Mol Genet (2008) 0.93
YY1 regulates melanocyte development and function by cooperating with MITF. PLoS Genet (2012) 0.93
Albinism: modern molecular diagnosis. Br J Ophthalmol (1998) 0.93
Study of total antioxidant status and glutathione peroxidase activity in Tunisian vitiligo patients. Indian J Dermatol (2009) 0.92
Klotho regulates retinal pigment epithelial functions and protects against oxidative stress. J Neurosci (2013) 0.91
The microphthalmia transcription factor (Mitf) controls expression of the ocular albinism type 1 gene: link between melanin synthesis and melanosome biogenesis. Mol Cell Biol (2004) 0.91
Regulation of the human tyrosinase gene in retinal pigment epithelium cells: the significance of transcription factor orthodenticle homeobox 2 and its polymorphic binding site. Mol Vis (2012) 0.90
A MITF mutation associated with a dominant white phenotype and bilateral deafness in German Fleckvieh cattle. PLoS One (2011) 0.89
A novel missense mutation of the paired box 3 gene in a Turkish family with Waardenburg syndrome type 1. Mol Vis (2013) 0.89
Melanoma biology and the promise of zebrafish. Zebrafish (2008) 0.88
Congenital hearing impairment. Pediatr Radiol (2006) 0.88
Localization of a novel gene for congenital nonsyndromic simple microphthalmia to chromosome 2q11-14. Hum Genet (2007) 0.88
Genetic and phenotypic heterogeneity in Chinese patients with Waardenburg syndrome type II. PLoS One (2013) 0.87
Coat colour in dogs: identification of the merle locus in the Australian shepherd breed. BMC Vet Res (2006) 0.86
A genome-wide linkage scan in Tunisian families identifies a novel locus for non-syndromic posterior microphthalmia to chromosome 2q37.1. Hum Genet (2009) 0.85
Mechanisms for reaching the differentiated state: Insights from neural crest-derived melanocytes. Semin Cell Dev Biol (2008) 0.84
PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1. Mol Vis (2010) 0.84
Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice. J Cell Physiol (2009) 0.84
A simple repeat polymorphism in the MITF-M promoter is a key regulator of white spotting in dogs. PLoS One (2014) 0.83
The incidence of deafness is non-randomly distributed among families segregating for Waardenburg syndrome type 1 (WS1). J Med Genet (1997) 0.83
Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q. J Med Genet (1995) 0.83
Novel and recurrent non-truncating mutations of the MITF basic domain: genotypic and phenotypic variations in Waardenburg and Tietz syndromes. Eur J Hum Genet (2012) 0.82
Molecular Study of Three Lebanese and Syrian Patients with Waardenburg Syndrome and Report of Novel Mutations in the EDNRB and MITF Genes. Mol Syndromol (2011) 0.81
Hearing dysfunction in heterozygous Mitf(Mi-wh) /+ mice, a model for Waardenburg syndrome type 2 and Tietz syndrome. Pigment Cell Melanoma Res (2012) 0.81
Mitfmi-enu122 is a missense mutation in the HLH dimerization domain. Mamm Genome (1998) 0.81
Genetic analysis of an Indian family with members affected with Waardenburg syndrome and Duchenne muscular dystrophy. Mol Vis (2012) 0.81
A de novo silencer causes elimination of MITF-M expression and profound hearing loss in pigs. BMC Biol (2016) 0.80
Septo-optic dysplasia and WS1 in the proband of a WS1 family segregating for a novel mutation in PAX3 exon 7. J Med Genet (1998) 0.79
FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy. Int J Cardiol (2015) 0.79
The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology. Lab Invest (2017) 0.78
Genetics of Hearing Loss: Syndromic. Otolaryngol Clin North Am (2015) 0.77
Enlarged vestibular aqueduct: Looking for genotypic-phenotypic correlations. Eur Arch Otorhinolaryngol (2006) 0.77
Manifestations of microphthalmia. Nat Genet (1994) 0.77
Microphthalmia-associated transcription factor mutations are associated with white-spotted coat color in swamp buffalo. Anim Genet (2015) 0.76
Understanding Melanocyte Stem Cells for Disease Modeling and Regenerative Medicine Applications. Int J Mol Sci (2015) 0.76
Organ of Corti and Stria Vascularis: Is there an Interdependence for Survival? PLoS One (2016) 0.75
Cellular and ultrastructural characterization of the grey-morph phenotype in southern right whales (Eubalaena australis). PLoS One (2017) 0.75
Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation. J Clin Invest (2016) 0.75
Functional analysis of a nonstop mutation in MITF gene identified in a patient with Waardenburg syndrome type 2. J Hum Genet (2017) 0.75
The Hearing Outcomes of Cochlear Implantation in Waardenburg Syndrome. Biomed Res Int (2016) 0.75
Clinical and genetic investigation of families with type II Waardenburg syndrome. Mol Med Rep (2016) 0.75
Molecular Etiology of Hereditary Single-Side Deafness: Its Association With Pigmentary Disorders and Waardenburg Syndrome. Medicine (Baltimore) (2015) 0.75
Differential evolution of duplicated medakafish mitf genes. Int J Biol Sci (2013) 0.75
Biallelic Mutations in MITF Cause Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, and Deafness. Am J Hum Genet (2016) 0.75
TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF. PLoS Genet (2017) 0.75
A Novel Pathogenic Variant in the MITF Gene Segregating with a Unique Spectrum of Ocular Findings in an Extended Iranian Waardenburg Syndrome Kindred. Mol Syndromol (2017) 0.75
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02
SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet (1998) 3.82
Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature (1992) 3.63
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68
Waardenburg syndrome. J Med Genet (1997) 2.66
Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein. Br J Obstet Gynaecol (1980) 2.50
Consanguinity and complex cardiac anomalies with situs ambiguus. Arch Dis Child (1984) 2.21
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
PAX genes. Curr Opin Genet Dev (1994) 1.92
Guidelines for DNA banking. Report of the Clinical Genetics Society working party on DNA banking. J Med Genet (1989) 1.91
An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with autosomal dominant cutis laxa. Hum Mol Genet (1998) 1.75
Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2. Nat Genet (1993) 1.67
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet (1997) 1.64
Williams syndrome: use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes. Am J Hum Genet (1999) 1.62
Aetiology of bilateral sensori-neural hearing loss in young children. J Laryngol Otol Suppl (1985) 1.56
The mutational spectrum in Waardenburg syndrome. Hum Mol Genet (1995) 1.55
Hypomelanosis of Ito: a manifestation of mosaicism or chimerism. J Med Genet (1988) 1.54
A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1. Nat Genet (1994) 1.44
Elastin: mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet (2000) 1.40
Assignment of the locus for Waardenburg syndrome type I to human chromosome 2q37 and possible homology to the Splotch mouse. Am J Hum Genet (1990) 1.37
Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet (1995) 1.32
Elastin: genomic structure and point mutations in patients with supravalvular aortic stenosis. Hum Mol Genet (1997) 1.31
Using case study comparisons to explore genotype-phenotype correlations in Williams-Beuren syndrome. J Med Genet (2003) 1.31
Neural tube defect recurrence after 'partial' vitamin supplementation. J Med Genet (1989) 1.27
The gene for Treacher Collins syndrome maps to the long arm of chromosome 5. Am J Hum Genet (1991) 1.19
Wolf-Hirschhorn locus is distal to D4S10 on short arm of chromosome 4. J Med Genet (1987) 1.17
A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies. Hum Mol Genet (1999) 1.17
Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis. Hum Genet (1986) 1.17
Stress after amniocentesis for high serum alpha-fetoprotein concentrations. Br Med J (1980) 1.17
Norrie disease resulting from a gene deletion: clinical features and DNA studies. J Med Genet (1988) 1.17
PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse. Hum Mol Genet (1994) 1.16
New uncertainties in prenatal screening for neural tube defect. Br Med J (Clin Res Ed) (1981) 1.16
LIM-kinase deleted in Williams syndrome. Nat Genet (1996) 1.15
Clinic experience of prenatal diagnosis of cystic fibrosis by use of linked DNA probes. Lancet (1987) 1.15
Mutation of the MITF gene in albinism-deafness syndrome (Tietz syndrome). Clin Dysmorphol (1998) 1.15
Diploid/triploid mixoploidy and hypomelanosis of Ito. Lancet (1986) 1.10
Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res (1994) 1.10
Waardenburg syndrome type II: phenotypic findings and diagnostic criteria. Am J Med Genet (1995) 1.09
Mutations in PAX1 may be associated with Klippel-Feil syndrome. Eur J Hum Genet (2003) 1.06
Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome. J Med Genet (1988) 1.02
Bridging markers defining the map position of X linked hypophosphataemic rickets. J Med Genet (1987) 1.02
Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations. Hum Genet (1998) 1.02
Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer (1997) 1.02
Monozygotic twinning and Wiedemann-Beckwith syndrome. Am J Med Genet (1992) 1.01
Neural-tube defects and vitamins: the need for a randomized clinical trial. Br J Obstet Gynaecol (1985) 1.00
Recurrent Wiedemann-Beckwith syndrome with inversion of chromosome (11)(p11.2p15.5). Am J Med Genet (1992) 0.98
Huntington's disease: testing the test. Nat Genet (1993) 0.98
A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome. Eur J Hum Genet (2000) 0.97
The gene for X-linked hypophosphataemic rickets maps to a 200-300kb region in Xp22.1, and is located on a single YAC containing a putative vitamin D response element (VDRE). Hum Genet (1996) 0.96
Congenital non-syndromal sensorineural hearing impairment due to connexin 26 gene mutations--molecular and audiological findings. Int J Pediatr Otorhinolaryngol (1999) 0.95
Association of pigmentary anomalies with chromosomal and genetic mosaicism and chimerism. Am J Hum Genet (1990) 0.93
Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res (1999) 0.92
DNA probes in differential diagnosis of Becker muscular dystrophy and spinal muscular atrophy. Lancet (1989) 0.92
A register based system for gene tracking in Duchenne muscular dystrophy. J Med Genet (1986) 0.91
Vitamin supplementation and neural tube defects. Lancet (1982) 0.90
Estimation of the male and female mutation rates in Duchenne muscular dystrophy (DMD). Hum Genet (1992) 0.90
Nucleotides. XLIX. The reduction of the adduct of periodate-oxidised adenosine-5' phosphate and methylamine. J Chem Soc Perkin 1 (1965) 0.89
New DNA markers in the Huntington's disease gene candidate region. Somat Cell Mol Genet (1991) 0.89
Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas. J Med Genet (1998) 0.88
X-linked and FSH dystrophies in one family. Neuromuscul Disord (1991) 0.88
Noise levels within the ear and post-nasal space in neonates in intensive care. Arch Dis Child Fetal Neonatal Ed (2003) 0.87
DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer (1999) 0.86
A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. I. Clinical features of neurofibromatosis in patients with unilateral vestibular schwannomas. J Laryngol Otol (1996) 0.85
Recurrent neural tube defects, risk factors and vitamins. Arch Dis Child (1986) 0.85
Haemangioma of the cord: further cause of raised maternal serum and liquor alpha-fetoprotein. Br Med J (1980) 0.84
Identification of a new mutation of the myosin VII head region in Usher syndrome type 1. Hum Mutat (1997) 0.84
Is there a genetic basis for Fuchs' heterochromic uveitis? Discordance in monozygotic twins. Br J Ophthalmol (1992) 0.84
Linkage analysis of two cloned DNA sequences, DXS197 and DXS207, in hypophosphatemic rickets families. Genomics (1990) 0.84
Waardenburg syndrome type 2 in a Turkish family: implications for the importance of the pattern of fundus pigmentation. Br J Ophthalmol (2001) 0.84
A complete physical contig and partial transcript map of the Williams syndrome critical region. Genomics (1999) 0.83
Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q. J Med Genet (1995) 0.83
Pax genes--paired feet in three camps. Nat Genet (1995) 0.82
Sound localisation in children with a severe unilateral hearing loss. Audiology (1983) 0.81
Symptomatic congenital cytomegalovirus infection after maternal recurrent infection. Pediatr Infect Dis J (1994) 0.81
Coinheritance of two rare genodermatoses (Papillon-Lefèvre syndrome and oculocutaneous albinism type 1) in two families: a genetic study. Br J Dermatol (2004) 0.80
Recombination or heterogeneity: is there a second locus for adult polycystic kidney disease? J Med Genet (1990) 0.80
Diagnosis of adult polycystic kidney disease by genetic markers and ultrasonographic imaging in a voluntary family register. J Med Genet (1994) 0.80
Mapping of the X linked form of hyper IgM syndrome (HIGM1) J Med Genet (1993) 0.79
Linkage studies of non-syndromic recessive deafness (NSRD) in a family originating from the Mirpur region of Pakistan maps DFNB1 centromeric to D13S175. Hum Mol Genet (1996) 0.79
Otoacoustic emissions in 28 young adults exposed to amplified music. Br J Audiol (1999) 0.78
Amniotic fluid acetylcholinesterase: a retrospective and prospective study of the qualitative method. Br J Obstet Gynaecol (1982) 0.77
Beckwith-Wiedemann syndrome. J Med Genet (1992) 0.76
Three DNA markers for hypophosphataemic rickets. Hum Genet (1992) 0.76
The genetics of otosclerosis: pedigree studies and linkage analysis. Adv Otorhinolaryngol (2007) 0.76
Possible maternal effect in genetic susceptibility to myasthenia gravis. Lancet (1986) 0.75
A clinical, genetic and audiological study of patients and families with unilateral vestibular schwannomas. II. Audiological findings in 93 patients with unilateral vestibular schwannomas. J Laryngol Otol (1996) 0.75
Preimplantation diagnosis with the polymerase chain reaction. BMJ (1989) 0.75
Testing for cystic fibrosis using allelic association. J Med Genet (1989) 0.75
New uncertainties in prenatal screening for neural tube defect. Br Med J (Clin Res Ed) (1981) 0.75
Spina bifida and vitamins. Br Med J (Clin Res Ed) (1983) 0.75
Hypomelanosis of Ito. Lancet (1992) 0.75
A clinical, genetic and audiological study of patients and families with bilateral acoustic neurofibromatosis. J Laryngol Otol (1993) 0.75